CHAT at HOME Pilot Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03661918 |
|
Recruitment Status :
Completed
First Posted : September 7, 2018
Last Update Posted : September 25, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Childhood Obesity | Behavioral: In-Person First Session Behavioral: Second Caregiver Behavioral: WiFi-enabled Scale Behavioral: 10 Core Coaching Calls Only | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 32 participants |
| Allocation: | Randomized |
| Intervention Model: | Factorial Assignment |
| Intervention Model Description: | This study is a 2 x 2 x 2 randomized clinical trial. In addition to the 10 core coaching sessions, there will be three additional components available to participants, depending on the experimental condition to which they are randomized. These potential additional components include 1) the first session being conducted in person, 2) involving a second adult caregiver, and 3) a weekly weighing of child via WiFi-enabled scales. |
| Masking: | Single (Participant) |
| Primary Purpose: | Other |
| Official Title: | Changing Habits Together at Home Pilot Study |
| Actual Study Start Date : | November 27, 2018 |
| Actual Primary Completion Date : | September 1, 2019 |
| Actual Study Completion Date : | September 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Group 1
In-person first session, no second caregiver, no wifi-enabled scale
|
Behavioral: In-Person First Session
Conduct first session in person vs. over the phone |
|
Group 2
In-person first session, no second caregiver, wifi-enabled scale
|
Behavioral: In-Person First Session
Conduct first session in person vs. over the phone Behavioral: WiFi-enabled Scale Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale |
|
Group 3
In-person first session, second caregiver, no wifi-enabled scale
|
Behavioral: In-Person First Session
Conduct first session in person vs. over the phone Behavioral: Second Caregiver Have second caregiver participate in three coaching calls |
|
Group 4
In-person first session, second caregiver, wifi-enabled scale
|
Behavioral: In-Person First Session
Conduct first session in person vs. over the phone Behavioral: Second Caregiver Have second caregiver participate in three coaching calls Behavioral: WiFi-enabled Scale Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale |
|
Group 5
No in-person first session, no second caregiver, no wifi-enabled scale. 10 core coaching calls only
|
Behavioral: 10 Core Coaching Calls Only
Participant will receive 10 core phone coaching sessions |
|
Group 6
No in-person first session, no second caregiver, wifi-enabled scale
|
Behavioral: WiFi-enabled Scale
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale |
|
Group 7
No in-person first session, second caregiver, no wifi-enabled scale
|
Behavioral: Second Caregiver
Have second caregiver participate in three coaching calls |
|
Group 8
No in-person first session, second caregiver, wifi-enabled scale
|
Behavioral: Second Caregiver
Have second caregiver participate in three coaching calls Behavioral: WiFi-enabled Scale Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale |
- Feasibility Data [ Time Frame: 4 months ]Demonstrate feasibility and acceptability of the intervention components as measured by high participation rates in and satisfaction with all experimental arms.
- Child BMI [ Time Frame: 4 months ]Track and measure child BMI percentiles at beginning and end of study.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 8 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Parent/primary caregiver of child in the 8-12 year old age range based on child birth date
- The child's BMI is greater than or equal to the 85th percentile according to CDC age and sex reference standards
- Child lives with parent/primary caregiver 50% of the time
- Willing to have a second caregiver participate in this study
- Wifi at home
- The parent and child can speak, read, and understand English
Exclusion Criteria:
- Kidney disease, Type 1 diabetes, Lupus, current Cancer diagnosis,
- Chromosomal abnormality such as Down's syndrome or Turner's syndrome
- Child taken any steroid medications such as Prednisone, Prenisilone and Decadron on a daily basis for more than 1 month in the past 6 months (this does not include inhalers with steroids)
- Child enrolled in a different weight management program
- Family participating in any other child research study related to dietary intake, physical activity, weight
- Plans to move more than 50 miles from your present location within the next 6 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03661918
| United States, Minnesota | |
| University of Minnesota | |
| Minneapolis, Minnesota, United States, 55454 | |
| Principal Investigator: | Nancy Sherwood, PhD | University of Minnesota |
| Responsible Party: | University of Minnesota |
| ClinicalTrials.gov Identifier: | NCT03661918 |
| Other Study ID Numbers: |
STUDY00004193 |
| First Posted: | September 7, 2018 Key Record Dates |
| Last Update Posted: | September 25, 2019 |
| Last Verified: | September 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Parent, adolescent, coaching, weight loss |
|
Pediatric Obesity Obesity Overnutrition |
Nutrition Disorders Overweight Body Weight |

